fda bpc-157 not approved human use statement An advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with The Precision Peptide Company (BPC)

A scoping review of the literature

GLP-1R (glucagon-like peptide-1) Natural GLP-1 lasts only a minute or two before an enzyme inactivates it, so most of its signal stays near the gut

Very rarely, some people experience: Mild itching or redness at injection site (if using injection) Slight weight gain (from better nutrient absorption) Compared to: NSAIDs (stomach ulcers, bleeding) Cortisone (weakens bones, immune suppression) Surgery (weeks of recovery) BPC-157 is remarkably safe References Chang, C

The peptide does not bind to a single identified receptor but instead modulates several biological systems simultaneously